PILA PHARMA AB
556966-4831ActiveClinical stage biotech developing an oral obesity and diabetes treatment.
Clinical Stage Biotech Companypilapharma.com
Yleiskatsaus
- 1–4
- Työntekijät
- 750–999t SEK
- Liikevaihto
- 2014
- Perustettu
Kuvaus
PILA PHARMA is a clinical stage biotechnology company focused on innovative drug development. The organization is pioneering the development of XEN-D0501, an oral TRPV1-antagonist. This drug candidate is being positioned as a potential first-in-class treatment for serious conditions like obesity and...
Tunnisteet
B2BHealthcarePharmaceuticals
Avainsanat
BiotechClinical Stage